InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Lawlis V Bryan, Director. Officer active across 2 companies, notably Biomarin Pharmaceutical INC. In total, 9 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. History available since 25 May 2021. The latest transaction was filed on 9 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lawlis V Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
13,300 shares@ US$1.17812.5% of flowCommon StockSEC:0000886744-25-000013:0
Canonical exit: 7 Aug 2025 (T+90)
35,000 shares@ US$1.9455.9% of flowCommon StockSEC:0000950170-24-061615:0
4,190 shares0Common StockSEC:0001209191-23-031973:0
35,000 shares@ US$1.1031.6% of flowCommon StockSEC:0001062993-23-010852:0
8,500 shares@ US$67.8155.4% of flowCommon StockSEC:0001209191-23-023062:0
4,980 shares0Common StockSEC:0001567619-22-011796:0
4,250 shares@ US$37.460.0013% mcap34.6% of flowCommon StockSEC:0001567619-22-008633:0
4,250 shares@ US$37.4617.1% of flowCommon StockSEC:0001567619-22-001334:0
5,120 shares0Common StockSEC:0001567619-21-011314:0
9 of 9 declarations
About Lawlis V Bryan
Bryan V. Lawlis is a Director at BIOMARIN PHARMACEUTICAL INC. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for BIOMARIN.
